, Tracking Stock Market Picks
Enter Symbol:
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

up 72.02 %

Auxilium Pharmaceuticals, Inc. (AUXL) rated Buy with price target $41 by Deutsche Securities

Posted on: Tuesday,  Sep 15, 2009  8:25 AM ET by Deutsche Securities

Deutsche Securities rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 09/15/2009. Previously Deutsche Securities rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on
11/03/2008., when the stock price was $21.20. Since then, Auxilium Pharmaceuticals, Inc. has gained 72.03% as of 01/29/2015's recent price of $36.47.
If you would have followed the previous Deutsche Securities's recommendation on AUXL, you would have gained 72.02% of your investment in 2278 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

Deutsche Bank's award-winning Research team manages a range of functions from asset allocation, through economic forecasting across a broad range of industry sectors including cement and construction, chemicals, electronics, energy, engineering, machinery, media, software, tobacco, retailing and utilities, and oil and gas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/15/2009 8:25 AM Buy
36.96 41.00
as of 12/31/2009
1 Week down  -26.87 %
1 Month down  -36.16 %
3 Months down  -34.93 %
1 YTD down  -21.72 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/20/2009 12:25 PM Buy
29.46 34.00
11/3/2008 8:25 AM Buy
21.20 29.00
2/15/2008 12:25 PM Hold
34.06 31.00
11/1/2007 1:25 PM Hold
26.11 22.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy